TABLE OF CONTENTS
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 RESEARCH METHODOLOGY
1.4.1 MARKET SIZE
1.4.2 MARKET SHARE
1.4.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.4.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.4.5 ASSUMPTIONS
1.5 STAKEHOLDERS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 INCREASING INCIDENCE OF NEUROLOGICAL DISORDERS TO SPUR MARKET GROWTH
3.3.1.2 UNPRECEDENTED GLOBAL AGING TO FUEL MARKET GROWTH
3.3.1.3 STRONG PRODUCT PIPELINE TO PROPEL THE MARKET
3.3.1.4 EXPANDED TARGET APPLICATIONS AND NEW INDICATIONS ARE EXPECTED TO STIMULATE GROWTH OF NEUROMODULATION DEVICES
3.3.1.5 INVESTMENTS AND FUNDS – AN IMPETUS FOR MARKET GROWTH
3.4 RESTRAINTS
3.4.1.1 AN UNFAVOURABLE REIMBURSEMENT SCENARIO HINDERS MARKET GROWTH
3.4.1.2 LACK OF TRAINED PROFESSIONALS LIKELY TO HAMPER MARKET GROWTH
3.5 MARKET SHARE ANALYSIS
4 GLOBAL NEUROMODULATION MARKET (INTERNAL & EXTERNAL)
4.1 INTRODUCTION
4.2 INTERNAL STIMULATION
4.2.1 SPINAL CORD STIMULATION (SCS) MARKET
4.2.1.1 MAJOR APPLICATIONS
4.2.1.1.1 FAILED BACK SURGERY SYNDROME
4.2.1.1.2 CHRONIC PAIN
4.2.1.1.3 ISCHEMIA
4.2.2 DEEP BRAIN STIMULATION (DBS)
4.2.2.1 MAJOR APPLICATIONS
4.2.2.1.1 PARKINSON’S DISEASE
4.2.2.1.2 DYSTONIA
4.2.2.1.3 TREMOR
4.2.2.1.4 ALZHEIMER’S
4.2.3 SACRAL NERVE STIMULATION (SNS)
4.2.3.1 MAJOR APPLICATIONS
4.2.3.1.1 URINE INCONTINENCE
4.2.3.1.2 FECAL INCONTINENCE
4.2.4 VAGUS NERVE STIMULATION (VNS)
4.2.4.1 MAJOR APPLICATIONS
4.2.4.1.1 EPILEPSY
4.2.4.1.2 OTHERS
4.2.5 GASTRIC ELECTRICAL STIMULATION (GES)
4.3 EXTERNAL STIMULATION
4.3.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
4.3.2 TRANSCRANIAL MAGNETIC STIMULATION (TMS)
5 GEOGRAPHIC ANALYSIS
5.1 INTRODUCTION
5.2 NORTH AMERICA
5.3 EUROPE
5.4 ASIA
5.5 REST OF THE WORLD
6 COMPETITIVE LANDSCAPE
6.1 INTRODUCTION
6.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS & JOINT VENTURES
6.3 NEW PRODUCT LAUNCH
6.4 EXPANSION
6.5 OTHER DEVELOPMENTS
6.6 APPROVALS
7 COMPANY PROFILES (OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)*
7.1 ANM ADAPTIVE NEUROMODULATION GMBH
7.2 BIOCONTROL MEDICAL, LTD.
7.3 BOSTON SCIENTIFIC CORPORATION
7.4 CERBOMED GMBH
7.5 CYBERONICS, INC.
7.6 ENDOSTIM, INC.
7.7 ENTEROMEDICS, INC.
7.8 THE MAGSTIM COMPANY LIMITED
7.9 MEDTRONIC, INC.
7.10 NEURONETICS, INC.
7.11 NEUROPACE, INC.
7.12 NEUROSIGMA, INC.
7.13 NEVRO CORPORATION
7.14 RS MEDICAL
7.15 SPINAL MODULATION, INC.
7.16 ST. JUDE MEDICAL
7.17 SYNAPSE BIOMEDICAL, INC.
7.18 UROPLASTY, INC.
7.19 ZYNEX, INC.
*DETAILS ON FINANCIALS, PRODUCT & SERVICES, STRATEGY, AND DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
TABLE 1 GLOBAL NEUROMODULATION MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 2 GLOBAL NEUROMODULATION MARKET, BY MODALITY,2010 - 2017 ($MILLION)
TABLE 3 SCS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 4 SCS MARKET VOLUME, BY GEOGRAPHY,2010 - 2017 (NO OF UNITS)
TABLE 5 GLOBAL SCS MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 6 DBS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 7 DBS MARKET VOLUME, BY GEOGRAPHY,2010-2017 (NO OF UNITS)
TABLE 8 GLOBAL DBS MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 9 SNS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 10 SNS MARKET VOLUME, BY GEOGRAPHY,2010 - 2017 (NO OF UNITS)
TABLE 11 GLOBAL SNS MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 12 VNS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 13 VNS MARKET VOLUME, BY GEOGRAPHY,2010 - 2017 (NO OF UNITS)
TABLE 14 GLOBAL VNS MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 15 GES MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 16 GES MARKET VOLUME,BY GEOGRAPHY, 2010 - 2017 (NO OF UNITS)
TABLE 17 GLOBAL GES MARKET,BY APPLICATION, 2010-2017 ($MILLION)
TABLE 18 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET,BY GEOGRAPHY, 2010 - 2017($MILLION)
TABLE 19 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET VOLUME, BY GEOGRAPHY, 2010 - 2017 (NO OF UNITS)
TABLE 20 TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 21 TRANSCRANIAL MAGNETIC STIMULATION MARKET VOLUME,BY GEOGRAPHY, 2010 - 2017 (NO OF UNITS)
TABLE 22 GLOBAL TRANSCRANIAL MAGNETIC STIMULATION MARKET,BY APPLICATION, 2010 - 2017 ($MILLION)
TABLE 23 NEUROMODULATION DEVICES MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 24 EXTERNAL NEUROMODULATION DEVICES MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 25 INTERNAL NEUROMODULATION DEVICES MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 26 GLOBAL EXTERNAL NEUROMODULATION MARKET, BY MODALITY,2010 - 2017 ($MILLION)
TABLE 27 GLOBAL EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 - 2017 (NO OF UNITS)
TABLE 28 NORTH AMERICA: NEUROMODULATION DEVICES MARKET,BY PROCEDURE, 2010 - 2017 ($MILLION)
TABLE 29 NORTH AMERICA: INTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 30 NORTH AMERICA: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 31 NORTH AMERICA: EXTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 32 NORTH AMERICA: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 33 NORTH AMERICA: SCS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 34 NORTH AMERICA: DBS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 35 NORTH AMERICA: SNS, BY COUNTRY,2010 - 2017 ($MILLION)
TABLE 36 NORTH AMERICA: VNS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 37 NORTH AMERICA: GES MARKET,BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 38 NORTH AMERICA: TMS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 39 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 40 EUROPE: NEUROMODULATION DEVICES MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 41 EUROPE: INTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 42 EUROPE: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 43 EUROPE: EXTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 44 EUROPE: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 45 EUROPE: SCS MARKET, BY REGION,2010 - 2017 ($MILLION)
TABLE 46 EUROPE: DBS, BY REGION,2010 - 2017 ($MILLION)
TABLE 47 EUROPE: SNS, BY REGION,2010 - 2017 ($MILLION)
TABLE 48 EUROPE: VNS MARKET, BY REGION,2010 - 2017 ($MILLION)
TABLE 49 EUROPE: GES MARKET, BY REGION, 2010 - 2017 ($MILLION)
TABLE 50 EUROPE: TRANSCRANIAL MAGNETIC STIMULATION MARKET,BY REGION, 2010 - 2017 ($MILLION)
TABLE 51 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY REGION, 2010 - 2017 ($MILLION)
TABLE 52 ASIA: NEUROMODULATION DEVICES MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 53 ASIA: INTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 54 ASIA: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 55 ASIA: EXTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 56 ASIA: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 57 ASIA: SCS MARKET, BY COUNTRY,2010 - 2017 ($MILLION)
TABLE 58 ASIA: DBS MARKET, BY COUNTRY,2010 - 2017 ($MILLION)
TABLE 59 ASIA: SNS, BY COUNTRY,2010 - 2017 ($MILLION)
TABLE 60 ASIA: TMS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 61 ASIA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 62 ROW: NEUROMODULATION DEVICES MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 63 ROW: INTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 64 ROW: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 65 ROW: EXTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 66 ROW: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 67 ROW: SCS MARKET, BY REGION,2010 - 2017 ($MILLION)
TABLE 68 ROW: DBS MARKET, BY REGION,2010 - 2017 ($MILLION)
TABLE 69 ROW: SNS, BY REGION,2010 - 2017 ($MILLION)
TABLE 70 ROW: VNS MARKET, BY REGION,2010 - 2017 ($MILLION)
TABLE 71 ROW: GES MARKET, BY REGION,2010 - 2017 ($MILLION)
TABLE 72 ROW: TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY REGION, 2010 - 2017 ($MILLION)
TABLE 73 ROW: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY REGION, 2010 - 2017 ($MILLION)
TABLE 74 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS & JOINT VENTURES, 2010 - 2012
TABLE 75 NEW PRODUCT LAUNCH, 2010 - 2012
TABLE 76 EXPANSION, 2010 - 2012
TABLE 77 OTHER DEVELOPMENTS, 2010 - 2012
TABLE 78 APPROVALS, 2010 - 2012
TABLE 79 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 80 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 81 BOSTON SCIENTIFIC: TOTAL REVENUE, BY GEOGRAPHY,2009 - 2011 ($MILLION)
TABLE 82 CYBERONICS, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2009 - 2011 ($MILLION)
TABLE 83 CYBERONICS, INC.: TOTAL REVENUE, BY GEOGRAPHY,2009 - 2011 ($MILLION)
TABLE 84 MEDTRONIC, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2009 - 2011 ($MILLION)
TABLE 85 MEDTRONIC, INC: TOTAL REVENUE, BY SEGMENTS,2009 - 2011 ($MILLION)
TABLE 86 MEDTRONIC, INC.: TOTAL REVENUE, BY GEOGRAPHY,2009 - 2011 ($MILLION)
TABLE 87 ST. JUDE MEDICAL, INC: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 88 ST. JUDE MEDICAL, INC: TOTAL REVENUE, BY SEGMENTS,2009 - 2011 ($MILLION)
TABLE 89 ST. JUDE MEDICAL, INC: TOTAL REVENUE, BY GEOGRAPHY,2009 - 2011 ($MILLION)
TABLE 90 UROPLASTY, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2010-2012 ($MILLION)
TABLE 91 UROPLASTY, INC.: TOTAL REVENUE, BY GEOGRAPHY,2010 - 2012 ($MILLION)
TABLE 92 ZYNEX, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2009 - 2011 ($MILLION)
TABLE 93 ZYNEX, INC.: TOTAL REVENUE, BY SEGMENTS,2009 - 2011 ($MILLION)
LIST OF FIGURES
FIGURE 1 NEUROMODULATION MARKET SEGMENTATION
FIGURE 2 MARKET DYNAMICS
FIGURE 3 NEUROMODULATION MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 4 KEY GROWTH STRATEGIES, 2010 - 2012